Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1975 3
1977 2
1978 2
1979 4
1980 3
1981 1
1982 3
1983 5
1984 1
1985 5
1986 4
1987 1
1988 4
1989 3
1990 4
1991 6
1992 19
1993 11
1994 10
1995 9
1996 9
1997 5
1998 12
1999 10
2000 15
2001 10
2002 13
2003 10
2004 11
2005 10
2006 12
2007 11
2008 12
2009 5
2010 10
2011 16
2012 28
2013 21
2014 15
2015 22
2016 14
2017 20
2018 18
2019 15
2020 19
2021 15
2022 23
2023 15
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

465 results

Results by year

Filters applied: . Clear all
Page 1
Ataxia.
Ashizawa T, Xia G. Ashizawa T, et al. Continuum (Minneap Minn). 2016 Aug;22(4 Movement Disorders):1208-26. doi: 10.1212/CON.0000000000000362. Continuum (Minneap Minn). 2016. PMID: 27495205 Free PMC article. Review.
Ataxia.
Akbar U, Ashizawa T. Akbar U, et al. Among authors: ashizawa t. Neurol Clin. 2015 Feb;33(1):225-48. doi: 10.1016/j.ncl.2014.09.004. Neurol Clin. 2015. PMID: 25432731 Free PMC article. Review.
Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial.
Thornton CA, Moxley RT 3rd, Eichinger K, Heatwole C, Mignon L, Arnold WD, Ashizawa T, Day JW, Dent G, Tanner MK, Duong T, Greene EP, Herbelin L, Johnson NE, King W, Kissel JT, Leung DG, Lott DJ, Norris DA, Pucillo EM, Schell W, Statland JM, Stinson N, Subramony SH, Xia S, Bishop KM, Bennett CF. Thornton CA, et al. Among authors: ashizawa t. Lancet Neurol. 2023 Mar;22(3):218-228. doi: 10.1016/S1474-4422(23)00001-7. Lancet Neurol. 2023. PMID: 36804094 Clinical Trial.
A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer.
Iizuka A, Nonomura C, Ashizawa T, Kondou R, Ohshima K, Sugino T, Mitsuya K, Hayashi N, Nakasu Y, Maruyama K, Yamaguchi K, Akiyama Y. Iizuka A, et al. Among authors: ashizawa t. Clin Cancer Res. 2019 May 1;25(9):2925-2934. doi: 10.1158/1078-0432.CCR-17-3123. Epub 2019 Feb 8. Clin Cancer Res. 2019. PMID: 30737243
Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Zesiewicz TA, Wilmot G, Kuo SH, Perlman S, Greenstein PE, Ying SH, Ashizawa T, Subramony SH, Schmahmann JD, Figueroa KP, Mizusawa H, Schöls L, Shaw JD, Dubinsky RM, Armstrong MJ, Gronseth GS, Sullivan KL. Zesiewicz TA, et al. Among authors: ashizawa t. Neurology. 2018 Mar 6;90(10):464-471. doi: 10.1212/WNL.0000000000005055. Epub 2018 Feb 9. Neurology. 2018. PMID: 29440566 Free PMC article.
Spinocerebellar Ataxia Type 10.
Matsuura T, Ashizawa T. Matsuura T, et al. Among authors: ashizawa t. 2002 Apr 23 [updated 2019 Sep 19]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. 2002 Apr 23 [updated 2019 Sep 19]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 20301354 Free Books & Documents. Review.
Synaptic Loss in Spinocerebellar Ataxia Type 3 Revealed by SV2A Positron Emission Tomography.
Chen Z, Liao G, Wan N, He Z, Chen D, Tang Z, Long Z, Zou G, Peng L, Wan L, Wang C, Peng H, Shi Y, Tang Y, Li J, Li Y, Long T, Hou X, He L, Qiu R, Chen D, Wang J, Guo J, Shen L, Huang Y, Ashizawa T, Klockgether T, Tang B, Zhou M, Hu S, Jiang H. Chen Z, et al. Among authors: ashizawa t. Mov Disord. 2023 Jun;38(6):978-989. doi: 10.1002/mds.29395. Epub 2023 Apr 6. Mov Disord. 2023. PMID: 37023261
Primary and secondary ataxias.
Teive HA, Ashizawa T. Teive HA, et al. Among authors: ashizawa t. Curr Opin Neurol. 2015 Aug;28(4):413-22. doi: 10.1097/WCO.0000000000000227. Curr Opin Neurol. 2015. PMID: 26132530 Free PMC article. Review.
Emerging therapies in Friedreich's ataxia.
Aranca TV, Jones TM, Shaw JD, Staffetti JS, Ashizawa T, Kuo SH, Fogel BL, Wilmot GR, Perlman SL, Onyike CU, Ying SH, Zesiewicz TA. Aranca TV, et al. Among authors: ashizawa t. Neurodegener Dis Manag. 2016;6(1):49-65. doi: 10.2217/nmt.15.73. Neurodegener Dis Manag. 2016. PMID: 26782317 Free PMC article. Review.
465 results